Karina ThornCorporate Vice President, Head of Research, Global Nucleic Acid Therapies Research at Novo NordiskSpeaker
Agenda Sessions
Fireside chat: Novo Nordisk’s RNA Partnerships – 2024 Review and 2025 Outlook
, 16:30View Session